E-LIB Suche - Ergebnisse für: Akinci, Muhammed Bulent

1

Real-life comparison of the afatinib and first-generation t..:

Bilgin, Burak ; Sendur, Mehmet Ali Nahit ; Yucel, Sebnem...
Journal of Cancer Research and Clinical Oncology. 147 (2021) 7 - p. 2145-2152 , 2021

Link: https://doi.org/10.1007/..

2

Can the host immune response against SARS-CoV2 also cause a..:

Kahraman, Seda ; Akinci, Muhammed Bulent ; Sendur, Mehmet Ali Nahit.
Medical Oncology. 38 (2021) 8 - p. , 2021

Link: https://doi.org/10.1007/..

3

The effect of EML4-ALK break-apart ratio on crizotinib outc..:

Bilgin, Burak ; Şendur, Mehmet Ali Nahit ; Yücel, Şebnem...
Journal of Cancer Research and Clinical Oncology. 147 (2021) 9 - p. 2637-2643 , 2021

Link: https://doi.org/10.1007/..

4

Evaluation of dynamic serum thiol-disulphide homeostasis in..:

Bilgin, Burak ; Sendur, Mehmet AN. ; Hizal, Mutlu...
Journal of Oncological Sciences. 5 (2019) 2 - p. 60-64 , 2019

Link: https://doi.org/10.1016/..

5

Evaluation of dynamic serum thiol/disulfide homeostasis in ..:

Hizal, Mutlu ; Sendur, Mehmet A.N. ; Bilgin, Burak...
Journal of Oncological Sciences. 4 (2018) 1 - p. 1-4 , 2018

Link: https://doi.org/10.1016/..

6

Clinical Significance of HER2 Overexpression in Gastric and..:

Baykara, Meltem ; Benekli, Mustafa ; Ekinci, Ozgur...
Journal of Gastrointestinal Surgery. 19 (2015) 9 - p. 1565-1571 , 2015

Link: https://doi.org/10.1007/..

7

Comparison of Adjuvant Modified FOLFIRINOX with Other Adjuv..:

ÜRÜN, YÜKSEL ; EROL, CİHAN ; HAFIZOĞLU, EMRE...
1d184dd9-f0da-4ec0-be0b-ad7ee343f7ac. , 2023

Link: https://doi.org/10.5505/..

8

Unresectable Hepatocellular Carcinoma and Prognostic Factor..:

Kahraman, Seda ; Ateş, Öztürk ; GÜVEN, DENİZ CAN...
e8da78a4-bc06-43de-80fb-a44aa312909d. , 2023

Link: https://doi.org/10.37047..

9

Efficacy and safety of folfiri plus aflibercept in second-l..:

Erol, Cihan ; Şendur, Mehmet Ali Nahit ; Bilgetekin, İrem...
Journal of Cancer Research and Therapeutics. , 2022

Link: https://hdl.handle.net/2..

10

The real-life efficacy of the second line treatment strateg..:

Hızal, Mutlu ; Şendur, Mehmet Ali Nahit ; Bilgin, Burak...
Journal of Oncological Science. , 2022

Link: https://hdl.handle.net/2..

11

The Real-Life Efficacy of the Second Line Treatment Strateg..:

ÖZDEMİR, NURİYE ; Öksüzoğlu, Berna ; Yalçin, Bülent...
767efd93-a961-49a3-b6bd-b72d62ec063e. , 2022

Link: https://doi.org/10.37047..

12

Prognostic factors of perioperative FLOT regimen in operabl..:

EROL, Cihan ; SAKİN, Abdullah ; BAŞOGLU, Tuğba...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387859/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Prognostic factors of perioperative FLOT regimen in operabl..:

Türker, Sema ; Yalçin, Şuayib ; YILDIRIM, HASAN ÇAĞRI...
5b1dfa63-e49a-4d8e-b30c-0f57cbc15d5d. , 2022

Link: https://doi.org/10.55730..

14

Efficacy and safety of folfiri plus aflibercept in second-l..:

Erol, Cihan ; Şendur, Mehmet Ali Nahit ; Bilgetekin, İrem...
https://doi.org/10.4103/jcrt.jcrt_1104_21. , 2022

Link: https://hdl.handle.net/2..

15

Prognostic factors of perioperative FLOT regimen in operabl..:

Hizal, Mutlu ; Degerli, Ezgi ; Arak, Haci...
5b1dfa63-e49a-4d8e-b30c-0f57cbc15d5d. , 2022

Link: https://doi.org/10.55730..